Literature DB >> 20107033

Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3.

J U Holle, E Csernok, G Fredenhagen, M Backes, J P Bremer, W L Gross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20107033     DOI： 10.1136/ard.2009.109868

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

Review 1.  Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?

Authors:  Jan Willem Cohen Tervaert; Jan Damoiseaux
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

2.  Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.

Authors:  Deepak A Rao; Kevin Wei; Joseph F Merola; William R O'Brien; Samuel U Takvorian; Paul F Dellaripa; Peter H Schur
Journal:  J Rheumatol       Date:  2015-04-01       Impact factor: 4.666

3.  Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease.

Authors:  Maria Teresa Arias-Loste; Geovana Bonilla; Irene Moraleja; Michael Mahler; Miguel Angel Mieses; Beatriz Castro; Montserrat Rivero; Javier Crespo; Marcos López-Hoyos
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

Review 4.  Current and emerging techniques for ANCA detection in vasculitis.

Authors:  Elena Csernok; Frank Moosig
Journal:  Nat Rev Rheumatol       Date:  2014-06-03       Impact factor: 20.543

Review 5.  Twenty-eight years with antineutrophil cytoplasmic antibodies (ANCA): how to test for ANCA - evidence-based immunology?

Authors:  Elena Csernok; Julia U Holle
Journal:  Auto Immun Highlights       Date:  2010-07-10

6.  PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).

Authors:  Laura M Stinton; Chelsea Bentow; Michael Mahler; Gary L Norman; Bertus Eksteen; Andrew L Mason; Gilaad G Kaplan; Bjorn Lindkvist; Gideon M Hirschfield; Piotr Milkiewicz; Angela Cheung; Harry L A Janssen; Marvin J Fritzler
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

7.  Chemiluminescent immunoassay technology: what does it change in autoantibody detection?

Authors:  Luigi Cinquanta; Desré Ethel Fontana; Nicola Bizzaro
Journal:  Auto Immun Highlights       Date:  2017-06-24

Review 8.  Novel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodies.

Authors:  Johannes Schulte-Pelkum; Antonella Radice; Gary L Norman; Marcos Lόpez Hoyos; Gabriella Lakos; Carol Buchner; Lucile Musset; Makoto Miyara; Laura Stinton; Michael Mahler
Journal:  J Immunol Res       Date:  2014-06-05       Impact factor: 4.818

9.  Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.

Authors:  Mandy Sowa; Kai Grossmann; Ilka Knütter; Rico Hiemann; Nadja Röber; Ursula Anderer; Elena Csernok; Dimitrios P Bogdanos; Maria Orietta Borghi; Pier Luigi Meroni; Peter Schierack; Dirk Reinhold; Karsten Conrad; Dirk Roggenbuck
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.